Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.31 per share which missed the analyst consensus estimate of $0.36 by 13.89 percent. This is a 121.43 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $113.041 million which missed the analyst consensus estimate of $114.844 million by 1.57 percent. This is a 32.62 percent increase over sales of $85.239 million the same period last year.